Omicron 91% less likely to cause death in infected patients: CDC

The Omicron variant is significantly less severe than other strains of Covid-19, according to a report from the US Centres for Disease Control and Prevention

coronavirus
IANS Washington
2 min read Last Updated : Jan 13 2022 | 6:55 PM IST

The Omicron variant is significantly less severe than other strains of Covid-19, according to a report from the US Centres for Disease Control and Prevention (CDC).

According to the agency, the risk of hospitalisation from Omicron was half compared to the risk from the Delta variant, Daily Mail reported.

Among people hospitalised, they were 75 per cent less likely to require intensive care, and even the rate of mortality was 91 per cent lower than that of Delta.

While it has long been known by health officials and experts alike that the Omicron variant is not as deadly as its predecessor, it has led to some deaths in the UK, Australia, the US, and India.

Currently, the US is averaging 750,515 new cases every day, the second highest daily total recorded yet in the pandemic -- only trailing Tuesday's total - with 1,716 deaths being attributed to the virus each day.

While the variant has caused cases to triple to record numbers in recent weeks, deaths have not moved at a similar rate.

And the recent 10 per cent uptick in Covid deaths in the US is actually being caused by the Delta variant, not the highly prevalent Omicron strain, CDC chief Rochelle Walensky was quoted as saying at a news conference on Wednesday.

The CDC data also estimates that 98 per cent of active Covid cases in the US are of the Omicron variant.

The Delta variant, which dominated the latter half of 2021, is now relegated to only around two percent of cases, the report said.

If the variant spreads rapidly, and is unlikely to cause death, it could quickly burn through the population and begin to recede.

Experts and health officials are hopeful that the recent surge caused by the variant is showing signs of burning out, as it could run out of people to infect in the coming weeks, the report said.

--IANS

rvt/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus Vaccine

First Published: Jan 13 2022 | 6:55 PM IST

Next Story